Autologous Conditioned Plasma Therapy Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autologous Conditioned Plasma Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pure Platelet-Rich Plasma (P-PRP)
1.2.3 Leukocyte- and Platelet-Rich Plasma (LPRP)
1.2.4 Pure Platelet-Rich Fibrin (P-PRF)
1.2.5 Leukocyte- and Platelet-Rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Autologous Conditioned Plasma Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Orthopedic & Trauma Centers
1.3.6 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autologous Conditioned Plasma Therapy Market Perspective (2017-2028)
2.2 Autologous Conditioned Plasma Therapy Growth Trends by Region
2.2.1 Autologous Conditioned Plasma Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Autologous Conditioned Plasma Therapy Historic Market Size by Region (2017-2022)
2.2.3 Autologous Conditioned Plasma Therapy Forecasted Market Size by Region (2023-2028)
2.3 Autologous Conditioned Plasma Therapy Market Dynamics
2.3.1 Autologous Conditioned Plasma Therapy Industry Trends
2.3.2 Autologous Conditioned Plasma Therapy Market Drivers
2.3.3 Autologous Conditioned Plasma Therapy Market Challenges
2.3.4 Autologous Conditioned Plasma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autologous Conditioned Plasma Therapy Players by Revenue
3.1.1 Global Top Autologous Conditioned Plasma Therapy Players by Revenue (2017-2022)
3.1.2 Global Autologous Conditioned Plasma Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Autologous Conditioned Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autologous Conditioned Plasma Therapy Revenue
3.4 Global Autologous Conditioned Plasma Therapy Market Concentration Ratio
3.4.1 Global Autologous Conditioned Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autologous Conditioned Plasma Therapy Revenue in 2021
3.5 Autologous Conditioned Plasma Therapy Key Players Head office and Area Served
3.6 Key Players Autologous Conditioned Plasma Therapy Product Solution and Service
3.7 Date of Enter into Autologous Conditioned Plasma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autologous Conditioned Plasma Therapy Breakdown Data by Type
4.1 Global Autologous Conditioned Plasma Therapy Historic Market Size by Type (2017-2022)
4.2 Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Type (2023-2028)
5 Autologous Conditioned Plasma Therapy Breakdown Data by Application
5.1 Global Autologous Conditioned Plasma Therapy Historic Market Size by Application (2017-2022)
5.2 Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Autologous Conditioned Plasma Therapy Market Size (2017-2028)
6.2 North America Autologous Conditioned Plasma Therapy Market Size by Type
6.2.1 North America Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022)
6.2.2 North America Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028)
6.2.3 North America Autologous Conditioned Plasma Therapy Market Share by Type (2017-2028)
6.3 North America Autologous Conditioned Plasma Therapy Market Size by Application
6.3.1 North America Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022)
6.3.2 North America Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028)
6.3.3 North America Autologous Conditioned Plasma Therapy Market Share by Application (2017-2028)
6.4 North America Autologous Conditioned Plasma Therapy Market Size by Country
6.4.1 North America Autologous Conditioned Plasma Therapy Market Size by Country (2017-2022)
6.4.2 North America Autologous Conditioned Plasma Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Autologous Conditioned Plasma Therapy Market Size (2017-2028)
7.2 Europe Autologous Conditioned Plasma Therapy Market Size by Type
7.2.1 Europe Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022)
7.2.2 Europe Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028)
7.2.3 Europe Autologous Conditioned Plasma Therapy Market Share by Type (2017-2028)
7.3 Europe Autologous Conditioned Plasma Therapy Market Size by Application
7.3.1 Europe Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022)
7.3.2 Europe Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028)
7.3.3 Europe Autologous Conditioned Plasma Therapy Market Share by Application (2017-2028)
7.4 Europe Autologous Conditioned Plasma Therapy Market Size by Country
7.4.1 Europe Autologous Conditioned Plasma Therapy Market Size by Country (2017-2022)
7.4.2 Europe Autologous Conditioned Plasma Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size (2017-2028)
8.2 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type
8.2.1 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Autologous Conditioned Plasma Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application
8.3.1 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Autologous Conditioned Plasma Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Region
8.4.1 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Autologous Conditioned Plasma Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Autologous Conditioned Plasma Therapy Market Size (2017-2028)
9.2 Latin America Autologous Conditioned Plasma Therapy Market Size by Type
9.2.1 Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Autologous Conditioned Plasma Therapy Market Share by Type (2017-2028)
9.3 Latin America Autologous Conditioned Plasma Therapy Market Size by Application
9.3.1 Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Autologous Conditioned Plasma Therapy Market Share by Application (2017-2028)
9.4 Latin America Autologous Conditioned Plasma Therapy Market Size by Country
9.4.1 Latin America Autologous Conditioned Plasma Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Autologous Conditioned Plasma Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size (2017-2028)
10.2 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type
10.2.1 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Autologous Conditioned Plasma Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application
10.3.1 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Autologous Conditioned Plasma Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Country
10.4.1 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Autologous Conditioned Plasma Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Zimmer Biomet Inc.
11.1.1 Zimmer Biomet Inc. Company Details
11.1.2 Zimmer Biomet Inc. Business Overview
11.1.3 Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Introduction
11.1.4 Zimmer Biomet Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.1.5 Zimmer Biomet Inc. Recent Developments
11.2 Terumo Corporation
11.2.1 Terumo Corporation Company Details
11.2.2 Terumo Corporation Business Overview
11.2.3 Terumo Corporation Autologous Conditioned Plasma Therapy Introduction
11.2.4 Terumo Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.2.5 Terumo Corporation Recent Developments
11.3 AdiStem Ltd.
11.3.1 AdiStem Ltd. Company Details
11.3.2 AdiStem Ltd. Business Overview
11.3.3 AdiStem Ltd. Autologous Conditioned Plasma Therapy Introduction
11.3.4 AdiStem Ltd. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.3.5 AdiStem Ltd. Recent Developments
11.4 Arthrex, Inc.
11.4.1 Arthrex, Inc. Company Details
11.4.2 Arthrex, Inc. Business Overview
11.4.3 Arthrex, Inc. Autologous Conditioned Plasma Therapy Introduction
11.4.4 Arthrex, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.4.5 Arthrex, Inc. Recent Developments
11.5 Stryker Corporation
11.5.1 Stryker Corporation Company Details
11.5.2 Stryker Corporation Business Overview
11.5.3 Stryker Corporation Autologous Conditioned Plasma Therapy Introduction
11.5.4 Stryker Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.5.5 Stryker Corporation Recent Developments
11.6 Cesca Therapeutics, Inc.
11.6.1 Cesca Therapeutics, Inc. Company Details
11.6.2 Cesca Therapeutics, Inc. Business Overview
11.6.3 Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Introduction
11.6.4 Cesca Therapeutics, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.6.5 Cesca Therapeutics, Inc. Recent Developments
11.7 Biotechnology Institute BTI
11.7.1 Biotechnology Institute BTI Company Details
11.7.2 Biotechnology Institute BTI Business Overview
11.7.3 Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Introduction
11.7.4 Biotechnology Institute BTI Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.7.5 Biotechnology Institute BTI Recent Developments
11.8 Dr. PRP America LLC
11.8.1 Dr. PRP America LLC Company Details
11.8.2 Dr. PRP America LLC Business Overview
11.8.3 Dr. PRP America LLC Autologous Conditioned Plasma Therapy Introduction
11.8.4 Dr. PRP America LLC Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.8.5 Dr. PRP America LLC Recent Developments
11.9 EmCyte Corporation
11.9.1 EmCyte Corporation Company Details
11.9.2 EmCyte Corporation Business Overview
11.9.3 EmCyte Corporation Autologous Conditioned Plasma Therapy Introduction
11.9.4 EmCyte Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.9.5 EmCyte Corporation Recent Developments
11.10 Vivostat A/S
11.10.1 Vivostat A/S Company Details
11.10.2 Vivostat A/S Business Overview
11.10.3 Vivostat A/S Autologous Conditioned Plasma Therapy Introduction
11.10.4 Vivostat A/S Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.10.5 Vivostat A/S Recent Developments
11.11 Regen Lab SA
11.11.1 Regen Lab SA Company Details
11.11.2 Regen Lab SA Business Overview
11.11.3 Regen Lab SA Autologous Conditioned Plasma Therapy Introduction
11.11.4 Regen Lab SA Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.11.5 Regen Lab SA Recent Developments
11.12 Royal Biologics
11.12.1 Royal Biologics Company Details
11.12.2 Royal Biologics Business Overview
11.12.3 Royal Biologics Autologous Conditioned Plasma Therapy Introduction
11.12.4 Royal Biologics Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.12.5 Royal Biologics Recent Developments
11.13 Exactech, Inc.
11.13.1 Exactech, Inc. Company Details
11.13.2 Exactech, Inc. Business Overview
11.13.3 Exactech, Inc. Autologous Conditioned Plasma Therapy Introduction
11.13.4 Exactech, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.13.5 Exactech, Inc. Recent Developments
11.14 Plateltex S.R.O.
11.14.1 Plateltex S.R.O. Company Details
11.14.2 Plateltex S.R.O. Business Overview
11.14.3 Plateltex S.R.O. Autologous Conditioned Plasma Therapy Introduction
11.14.4 Plateltex S.R.O. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022)
11.14.5 Plateltex S.R.O. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Autologous Conditioned Plasma Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Pure Platelet-Rich Plasma (P-PRP)
Table 3. Key Players of Leukocyte- and Platelet-Rich Plasma (LPRP)
Table 4. Key Players of Pure Platelet-Rich Fibrin (P-PRF)
Table 5. Key Players of Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Table 6. Global Autologous Conditioned Plasma Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Autologous Conditioned Plasma Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Autologous Conditioned Plasma Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Autologous Conditioned Plasma Therapy Market Share by Region (2017-2022)
Table 10. Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Autologous Conditioned Plasma Therapy Market Share by Region (2023-2028)
Table 12. Autologous Conditioned Plasma Therapy Market Trends
Table 13. Autologous Conditioned Plasma Therapy Market Drivers
Table 14. Autologous Conditioned Plasma Therapy Market Challenges
Table 15. Autologous Conditioned Plasma Therapy Market Restraints
Table 16. Global Autologous Conditioned Plasma Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Autologous Conditioned Plasma Therapy Revenue Share by Players (2017-2022)
Table 18. Global Top Autologous Conditioned Plasma Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Conditioned Plasma Therapy as of 2021)
Table 19. Ranking of Global Top Autologous Conditioned Plasma Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Autologous Conditioned Plasma Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Autologous Conditioned Plasma Therapy Product Solution and Service
Table 23. Date of Enter into Autologous Conditioned Plasma Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Autologous Conditioned Plasma Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Autologous Conditioned Plasma Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Autologous Conditioned Plasma Therapy Revenue Share by Application (2017-2022)
Table 31. Global Autologous Conditioned Plasma Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Autologous Conditioned Plasma Therapy Revenue Share by Application (2023-2028)
Table 33. North America Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Autologous Conditioned Plasma Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Autologous Conditioned Plasma Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Autologous Conditioned Plasma Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Autologous Conditioned Plasma Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Autologous Conditioned Plasma Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Autologous Conditioned Plasma Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Autologous Conditioned Plasma Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Autologous Conditioned Plasma Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 63. Zimmer Biomet Inc. Company Details
Table 64. Zimmer Biomet Inc. Business Overview
Table 65. Zimmer Biomet Inc. Autologous Conditioned Plasma Therapy Product
Table 66. Zimmer Biomet Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 67. Zimmer Biomet Inc. Recent Developments
Table 68. Terumo Corporation Company Details
Table 69. Terumo Corporation Business Overview
Table 70. Terumo Corporation Autologous Conditioned Plasma Therapy Product
Table 71. Terumo Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 72. Terumo Corporation Recent Developments
Table 73. AdiStem Ltd. Company Details
Table 74. AdiStem Ltd. Business Overview
Table 75. AdiStem Ltd. Autologous Conditioned Plasma Therapy Product
Table 76. AdiStem Ltd. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 77. AdiStem Ltd. Recent Developments
Table 78. Arthrex, Inc. Company Details
Table 79. Arthrex, Inc. Business Overview
Table 80. Arthrex, Inc. Autologous Conditioned Plasma Therapy Product
Table 81. Arthrex, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 82. Arthrex, Inc. Recent Developments
Table 83. Stryker Corporation Company Details
Table 84. Stryker Corporation Business Overview
Table 85. Stryker Corporation Autologous Conditioned Plasma Therapy Product
Table 86. Stryker Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 87. Stryker Corporation Recent Developments
Table 88. Cesca Therapeutics, Inc. Company Details
Table 89. Cesca Therapeutics, Inc. Business Overview
Table 90. Cesca Therapeutics, Inc. Autologous Conditioned Plasma Therapy Product
Table 91. Cesca Therapeutics, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 92. Cesca Therapeutics, Inc. Recent Developments
Table 93. Biotechnology Institute BTI Company Details
Table 94. Biotechnology Institute BTI Business Overview
Table 95. Biotechnology Institute BTI Autologous Conditioned Plasma Therapy Product
Table 96. Biotechnology Institute BTI Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 97. Biotechnology Institute BTI Recent Developments
Table 98. Dr. PRP America LLC Company Details
Table 99. Dr. PRP America LLC Business Overview
Table 100. Dr. PRP America LLC Autologous Conditioned Plasma Therapy Product
Table 101. Dr. PRP America LLC Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 102. Dr. PRP America LLC Recent Developments
Table 103. EmCyte Corporation Company Details
Table 104. EmCyte Corporation Business Overview
Table 105. EmCyte Corporation Autologous Conditioned Plasma Therapy Product
Table 106. EmCyte Corporation Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 107. EmCyte Corporation Recent Developments
Table 108. Vivostat A/S Company Details
Table 109. Vivostat A/S Business Overview
Table 110. Vivostat A/S Autologous Conditioned Plasma Therapy Product
Table 111. Vivostat A/S Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 112. Vivostat A/S Recent Developments
Table 113. Regen Lab SA Company Details
Table 114. Regen Lab SA Business Overview
Table 115. Regen Lab SA Autologous Conditioned Plasma Therapy Product
Table 116. Regen Lab SA Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 117. Regen Lab SA Recent Developments
Table 118. Royal Biologics Company Details
Table 119. Royal Biologics Business Overview
Table 120. Royal Biologics Autologous Conditioned Plasma Therapy Product
Table 121. Royal Biologics Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 122. Royal Biologics Recent Developments
Table 123. Exactech, Inc. Company Details
Table 124. Exactech, Inc. Business Overview
Table 125. Exactech, Inc. Autologous Conditioned Plasma Therapy Product
Table 126. Exactech, Inc. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 127. Exactech, Inc. Recent Developments
Table 128. Plateltex S.R.O. Company Details
Table 129. Plateltex S.R.O. Business Overview
Table 130. Plateltex S.R.O. Autologous Conditioned Plasma Therapy Product
Table 131. Plateltex S.R.O. Revenue in Autologous Conditioned Plasma Therapy Business (2017-2022) & (US$ Million)
Table 132. Plateltex S.R.O. Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autologous Conditioned Plasma Therapy Market Share by Type: 2021 VS 2028
Figure 2. Pure Platelet-Rich Plasma (P-PRP) Features
Figure 3. Leukocyte- and Platelet-Rich Plasma (LPRP) Features
Figure 4. Pure Platelet-Rich Fibrin (P-PRF) Features
Figure 5. Leukocyte- and Platelet-Rich Fibrin (L-PRF) Features
Figure 6. Global Autologous Conditioned Plasma Therapy Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialized Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Orthopedic & Trauma Centers Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Autologous Conditioned Plasma Therapy Report Years Considered
Figure 13. Global Autologous Conditioned Plasma Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Autologous Conditioned Plasma Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Autologous Conditioned Plasma Therapy Market Share by Region: 2021 VS 2028
Figure 16. Global Autologous Conditioned Plasma Therapy Market Share by Players in 2021
Figure 17. Global Top Autologous Conditioned Plasma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Conditioned Plasma Therapy as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Autologous Conditioned Plasma Therapy Revenue in 2021
Figure 19. North America Autologous Conditioned Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Autologous Conditioned Plasma Therapy Market Size Market Share by Type (2017-2028)
Figure 21. North America Autologous Conditioned Plasma Therapy Market Size Market Share by Application (2017-2028)
Figure 22. North America Autologous Conditioned Plasma Therapy Market Size Share by Country (2017-2028)
Figure 23. United States Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Autologous Conditioned Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Autologous Conditioned Plasma Therapy Market Size Market Share by Type (2017-2028)
Figure 27. Europe Autologous Conditioned Plasma Therapy Market Size Market Share by Application (2017-2028)
Figure 28. Europe Autologous Conditioned Plasma Therapy Market Size Share by Country (2017-2028)
Figure 29. Germany Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Autologous Conditioned Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Autologous Conditioned Plasma Therapy Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Autologous Conditioned Plasma Therapy Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Autologous Conditioned Plasma Therapy Market Size Share by Region (2017-2028)
Figure 39. China Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Autologous Conditioned Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Autologous Conditioned Plasma Therapy Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Autologous Conditioned Plasma Therapy Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Autologous Conditioned Plasma Therapy Market Size Share by Country (2017-2028)
Figure 49. Mexico Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Autologous Conditioned Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Autologous Conditioned Plasma Therapy Market Size Share by Country (2017-2028)
Figure 55. Turkey Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Autologous Conditioned Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Zimmer Biomet Inc. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 59. Terumo Corporation Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 60. AdiStem Ltd. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 61. Arthrex, Inc. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 62. Stryker Corporation Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 63. Cesca Therapeutics, Inc. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 64. Biotechnology Institute BTI Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 65. Dr. PRP America LLC Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 66. EmCyte Corporation Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 67. Vivostat A/S Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 68. Regen Lab SA Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 69. Royal Biologics Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 70. Exactech, Inc. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 71. Plateltex S.R.O. Revenue Growth Rate in Autologous Conditioned Plasma Therapy Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Industry Market Size
